349 related articles for article (PubMed ID: 8710935)
21. SCH 57790: a novel M2 receptor selective antagonist.
Lachowicz JE; Lowe D; Duffy RA; Ruperto V; Taylor LA; Guzik H; Brown J; Berger JG; Tice M; McQuade R; Kozlowski J; Clader J; Strader CD; Murgolo N
Life Sci; 1999; 64(6-7):535-9. PubMed ID: 10069520
[TBL] [Abstract][Full Text] [Related]
22. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP
J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229
[TBL] [Abstract][Full Text] [Related]
23. Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors.
Matucci R; Bellucci C; Martino MV; Nesi M; Manetti D; Welzel J; Bartz U; Holze J; Tränkle C; Mohr K; Mazzolari A; Vistoli G; Dei S; Teodori E; Romanelli MN
Eur J Pharmacol; 2020 Sep; 883():173183. PubMed ID: 32534072
[TBL] [Abstract][Full Text] [Related]
24. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
25. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
Zhang LB; Buxton IL
Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
[TBL] [Abstract][Full Text] [Related]
27. A novel M3 muscarinic acetylcholine receptor is expressed in chick atrium and ventricle.
Gadbut AP; Galper JB
J Biol Chem; 1994 Oct; 269(41):25823-9. PubMed ID: 7929287
[TBL] [Abstract][Full Text] [Related]
28. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
Lee NH; el-Fakahany EE
J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
[TBL] [Abstract][Full Text] [Related]
29. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
Zhang LB; Horowitz B; Buxton IL
Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
[TBL] [Abstract][Full Text] [Related]
30. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
Daly JW; Gupta TH; Padgett WL; Pei XF
J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia.
Garnier M; Lamacz M; Galas L; Lenglet S; Tonon MC; Vaudry H
Endocrinology; 1998 Aug; 139(8):3525-33. PubMed ID: 9681504
[TBL] [Abstract][Full Text] [Related]
32. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
Jakubík J; Tucek S
J Neurochem; 1994 Nov; 63(5):1932-40. PubMed ID: 7931349
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation and desensitization of the muscarinic M1 and M2 receptors in transfected fibroblast B82 cells.
Wei HB; Yamamura HI; Roeske WR
Eur J Pharmacol; 1994 Aug; 268(3):381-91. PubMed ID: 7805762
[TBL] [Abstract][Full Text] [Related]
34. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
35. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS
Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263
[TBL] [Abstract][Full Text] [Related]
37. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.
Jakubík J; Randáková A; El-Fakahany EE; Dolezal V
BMC Pharmacol; 2009 Dec; 9():15. PubMed ID: 20038295
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative allosteric interactions on muscarinic receptors.
Hejnová L; Tucek S; el-Fakahany EE
Eur J Pharmacol; 1995 Nov; 291(3):427-30. PubMed ID: 8719429
[TBL] [Abstract][Full Text] [Related]
39. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.
Dolezal V; Tucek S
Br J Pharmacol; 1998 Jul; 124(6):1213-8. PubMed ID: 9720793
[TBL] [Abstract][Full Text] [Related]
40. Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors.
Tucek S; Jakubík J; Dolezal V; el-Fakahany EE
J Physiol Paris; 1998; 92(3-4):241-3. PubMed ID: 9789816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
